The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pf Ago Endonuclease Market Research Report 2024

Global Pf Ago Endonuclease Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1763949

No of Pages : 101

Synopsis
PfAgo endonuclease (Pf Ago Endonuclease) is derived from recombinant Escherichia coli, which contains the Argonaute (Ago) nuclease gene cloned from Pyrococcus furiosus. An endonuclease that specifically recognizes and cleaves the target nucleic acid. PfAgo endonuclease accurately cuts single-stranded DNA substrates under the guidance of 5' phosphorylated guide DNA (greater than 15 nt), and the cutting site is located at the 10th and 11th nuclei starting from the 5' end complementary to the guide sequence The cleavage between nucleotides is not restricted by the target sequence and the sequence adjacent to the cleavage site.

Global Pf Ago Endonuclease market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pf Ago Endonuclease market research.

Key manufacturers engaged in the Pf Ago Endonuclease industry include Thermo Fisher Scientific, Absin, New England Biolabs, Takara Bio, Illumina, Agilent, Promega, Jena Biosciences and Qiagen, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Pf Ago Endonuclease were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pf Ago Endonuclease market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pf Ago Endonuclease market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Thermo Fisher Scientific
  • Absin
  • New England Biolabs
  • Takara Bio
  • Illumina
  • Agilent
  • Promega
  • Jena Biosciences
  • Qiagen
  • GE Healthcare
  • Magigen
  • BIOFOUNT
  • Shanghai Yiyan Bio-Technology
  • Beijing Baiao Leibo Technology
  • Shanghai Hengfei Biotechnology

Segment by Type

  • Purity Less Than 90%
  • Purity 90%-98%
  • Purity Greater Than 98%

Segment by Application

  • Academic Research Institution
  • Hospitals And Diagnostic Centers
  • Biopharmaceutical
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Pf Ago Endonuclease report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Pf Ago Endonuclease Market Overview
1.1 Product Overview and Scope of Pf Ago Endonuclease
1.2 Pf Ago Endonuclease Segment by Type
1.2.1 Global Pf Ago Endonuclease Market Value Comparison by Type (2023-2029)
1.2.2 Purity Less Than 90%
1.2.3 Purity 90%-98%
1.2.4 Purity Greater Than 98%
1.3 Pf Ago Endonuclease Segment by Application
1.3.1 Global Pf Ago Endonuclease Market Value by Application: (2023-2029)
1.3.2 Academic Research Institution
1.3.3 Hospitals And Diagnostic Centers
1.3.4 Biopharmaceutical
1.3.5 Others
1.4 Global Pf Ago Endonuclease Market Size Estimates and Forecasts
1.4.1 Global Pf Ago Endonuclease Revenue 2018-2029
1.4.2 Global Pf Ago Endonuclease Sales 2018-2029
1.4.3 Global Pf Ago Endonuclease Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pf Ago Endonuclease Market Competition by Manufacturers
2.1 Global Pf Ago Endonuclease Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pf Ago Endonuclease Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pf Ago Endonuclease Average Price by Manufacturers (2018-2023)
2.4 Global Pf Ago Endonuclease Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pf Ago Endonuclease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pf Ago Endonuclease, Product Type & Application
2.7 Pf Ago Endonuclease Market Competitive Situation and Trends
2.7.1 Pf Ago Endonuclease Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pf Ago Endonuclease Players Market Share by Revenue
2.7.3 Global Pf Ago Endonuclease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pf Ago Endonuclease Retrospective Market Scenario by Region
3.1 Global Pf Ago Endonuclease Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pf Ago Endonuclease Global Pf Ago Endonuclease Sales by Region: 2018-2029
3.2.1 Global Pf Ago Endonuclease Sales by Region: 2018-2023
3.2.2 Global Pf Ago Endonuclease Sales by Region: 2024-2029
3.3 Global Pf Ago Endonuclease Global Pf Ago Endonuclease Revenue by Region: 2018-2029
3.3.1 Global Pf Ago Endonuclease Revenue by Region: 2018-2023
3.3.2 Global Pf Ago Endonuclease Revenue by Region: 2024-2029
3.4 North America Pf Ago Endonuclease Market Facts & Figures by Country
3.4.1 North America Pf Ago Endonuclease Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pf Ago Endonuclease Sales by Country (2018-2029)
3.4.3 North America Pf Ago Endonuclease Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pf Ago Endonuclease Market Facts & Figures by Country
3.5.1 Europe Pf Ago Endonuclease Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pf Ago Endonuclease Sales by Country (2018-2029)
3.5.3 Europe Pf Ago Endonuclease Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pf Ago Endonuclease Market Facts & Figures by Country
3.6.1 Asia Pacific Pf Ago Endonuclease Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pf Ago Endonuclease Sales by Country (2018-2029)
3.6.3 Asia Pacific Pf Ago Endonuclease Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pf Ago Endonuclease Market Facts & Figures by Country
3.7.1 Latin America Pf Ago Endonuclease Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pf Ago Endonuclease Sales by Country (2018-2029)
3.7.3 Latin America Pf Ago Endonuclease Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pf Ago Endonuclease Market Facts & Figures by Country
3.8.1 Middle East and Africa Pf Ago Endonuclease Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pf Ago Endonuclease Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pf Ago Endonuclease Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pf Ago Endonuclease Sales by Type (2018-2029)
4.1.1 Global Pf Ago Endonuclease Sales by Type (2018-2023)
4.1.2 Global Pf Ago Endonuclease Sales by Type (2024-2029)
4.1.3 Global Pf Ago Endonuclease Sales Market Share by Type (2018-2029)
4.2 Global Pf Ago Endonuclease Revenue by Type (2018-2029)
4.2.1 Global Pf Ago Endonuclease Revenue by Type (2018-2023)
4.2.2 Global Pf Ago Endonuclease Revenue by Type (2024-2029)
4.2.3 Global Pf Ago Endonuclease Revenue Market Share by Type (2018-2029)
4.3 Global Pf Ago Endonuclease Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pf Ago Endonuclease Sales by Application (2018-2029)
5.1.1 Global Pf Ago Endonuclease Sales by Application (2018-2023)
5.1.2 Global Pf Ago Endonuclease Sales by Application (2024-2029)
5.1.3 Global Pf Ago Endonuclease Sales Market Share by Application (2018-2029)
5.2 Global Pf Ago Endonuclease Revenue by Application (2018-2029)
5.2.1 Global Pf Ago Endonuclease Revenue by Application (2018-2023)
5.2.2 Global Pf Ago Endonuclease Revenue by Application (2024-2029)
5.2.3 Global Pf Ago Endonuclease Revenue Market Share by Application (2018-2029)
5.3 Global Pf Ago Endonuclease Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Scientific Pf Ago Endonuclease Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Absin
6.2.1 Absin Corporation Information
6.2.2 Absin Description and Business Overview
6.2.3 Absin Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Absin Pf Ago Endonuclease Product Portfolio
6.2.5 Absin Recent Developments/Updates
6.3 New England Biolabs
6.3.1 New England Biolabs Corporation Information
6.3.2 New England Biolabs Description and Business Overview
6.3.3 New England Biolabs Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.3.4 New England Biolabs Pf Ago Endonuclease Product Portfolio
6.3.5 New England Biolabs Recent Developments/Updates
6.4 Takara Bio
6.4.1 Takara Bio Corporation Information
6.4.2 Takara Bio Description and Business Overview
6.4.3 Takara Bio Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takara Bio Pf Ago Endonuclease Product Portfolio
6.4.5 Takara Bio Recent Developments/Updates
6.5 Illumina
6.5.1 Illumina Corporation Information
6.5.2 Illumina Description and Business Overview
6.5.3 Illumina Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Illumina Pf Ago Endonuclease Product Portfolio
6.5.5 Illumina Recent Developments/Updates
6.6 Agilent
6.6.1 Agilent Corporation Information
6.6.2 Agilent Description and Business Overview
6.6.3 Agilent Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Agilent Pf Ago Endonuclease Product Portfolio
6.6.5 Agilent Recent Developments/Updates
6.7 Promega
6.6.1 Promega Corporation Information
6.6.2 Promega Description and Business Overview
6.6.3 Promega Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Promega Pf Ago Endonuclease Product Portfolio
6.7.5 Promega Recent Developments/Updates
6.8 Jena Biosciences
6.8.1 Jena Biosciences Corporation Information
6.8.2 Jena Biosciences Description and Business Overview
6.8.3 Jena Biosciences Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Jena Biosciences Pf Ago Endonuclease Product Portfolio
6.8.5 Jena Biosciences Recent Developments/Updates
6.9 Qiagen
6.9.1 Qiagen Corporation Information
6.9.2 Qiagen Description and Business Overview
6.9.3 Qiagen Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Qiagen Pf Ago Endonuclease Product Portfolio
6.9.5 Qiagen Recent Developments/Updates
6.10 GE Healthcare
6.10.1 GE Healthcare Corporation Information
6.10.2 GE Healthcare Description and Business Overview
6.10.3 GE Healthcare Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GE Healthcare Pf Ago Endonuclease Product Portfolio
6.10.5 GE Healthcare Recent Developments/Updates
6.11 Magigen
6.11.1 Magigen Corporation Information
6.11.2 Magigen Pf Ago Endonuclease Description and Business Overview
6.11.3 Magigen Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Magigen Pf Ago Endonuclease Product Portfolio
6.11.5 Magigen Recent Developments/Updates
6.12 BIOFOUNT
6.12.1 BIOFOUNT Corporation Information
6.12.2 BIOFOUNT Pf Ago Endonuclease Description and Business Overview
6.12.3 BIOFOUNT Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BIOFOUNT Pf Ago Endonuclease Product Portfolio
6.12.5 BIOFOUNT Recent Developments/Updates
6.13 Shanghai Yiyan Bio-Technology
6.13.1 Shanghai Yiyan Bio-Technology Corporation Information
6.13.2 Shanghai Yiyan Bio-Technology Pf Ago Endonuclease Description and Business Overview
6.13.3 Shanghai Yiyan Bio-Technology Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shanghai Yiyan Bio-Technology Pf Ago Endonuclease Product Portfolio
6.13.5 Shanghai Yiyan Bio-Technology Recent Developments/Updates
6.14 Beijing Baiao Leibo Technology
6.14.1 Beijing Baiao Leibo Technology Corporation Information
6.14.2 Beijing Baiao Leibo Technology Pf Ago Endonuclease Description and Business Overview
6.14.3 Beijing Baiao Leibo Technology Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Beijing Baiao Leibo Technology Pf Ago Endonuclease Product Portfolio
6.14.5 Beijing Baiao Leibo Technology Recent Developments/Updates
6.15 Shanghai Hengfei Biotechnology
6.15.1 Shanghai Hengfei Biotechnology Corporation Information
6.15.2 Shanghai Hengfei Biotechnology Pf Ago Endonuclease Description and Business Overview
6.15.3 Shanghai Hengfei Biotechnology Pf Ago Endonuclease Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shanghai Hengfei Biotechnology Pf Ago Endonuclease Product Portfolio
6.15.5 Shanghai Hengfei Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pf Ago Endonuclease Industry Chain Analysis
7.2 Pf Ago Endonuclease Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pf Ago Endonuclease Production Mode & Process
7.4 Pf Ago Endonuclease Sales and Marketing
7.4.1 Pf Ago Endonuclease Sales Channels
7.4.2 Pf Ago Endonuclease Distributors
7.5 Pf Ago Endonuclease Customers
8 Pf Ago Endonuclease Market Dynamics
8.1 Pf Ago Endonuclease Industry Trends
8.2 Pf Ago Endonuclease Market Drivers
8.3 Pf Ago Endonuclease Market Challenges
8.4 Pf Ago Endonuclease Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’